The Use of D5LR Versus LR for Induction of Labor and Time to Delivery in Multiparous and Primiparous Patient's With Favorable and Unfavorable Bishop's Scores
A Randomized Controlled Trial Comparing D5LR to LR for Induction of Labor and Time to Delivery in Multiparous and Primiparous Patient's With Favorable and Unfavorable Bishop's Scores
Studie Overzicht
Toestand
Interventie / Behandeling
Gedetailleerde beschrijving
Induction of labor is increasingly common in the United States, as the overall rate has increased from 9.5% in 1990 to 22.1% in 2006 with the goal to stimulate contractions prior to the onset of spontaneous labor. Cesarean delivery rates are also at an all-time high in the U.S., with more than 32% of patients being delivered by Cesarean in 2009. One of the most common indications for Cesarean section is a prolonged labor course. Patient's with a prolonged labor course are also at risk for infections, including chorioamnionitis and endometritis, as well as an increased risk of postpartum hemorrhage. There is a lack of information on ways to help shorten labor to potentially minimize these risks.
The uterus is comprised of skeletal muscle, and labor has been likened to prolonged rigorous exercise. While oral hydration has been endorsed by ACOG for low-risk women in spontaneous labor, solid foods should be avoided. In turn, women with a prolonged induction or labor may benefit from glucose supplementation via IV fluids.
The DEXTRONS study, J. Pare et al., looked at supplementation of D5LR versus normal saline in nulliparous patients who presented for a favorable induction of labor. This study showed a significant reduction in active labor time in the D5LR group versus the normal saline group.
Currently, at Genesys Regional Medical Center, lactated ringers is the preferred IV fluid for patients presenting for induction of labor. This study will randomly assign patients to D5LR versus lactated ringers and examine the length of time from induction to delivery to determine if glucose supplementation has an effect on reducing length of induction in both nulliparous and multiparous patients for either a favorable induction of labor or an induction for post-dates. Secondary outcomes will include Apgar scores, need for special care nursery/NICU admissions, and mode of delivery. The study will begin in January 2019 and continue through July 2019. Patients who presented to labor and delivery and consent to be included in the study will be randomized to each group.
Studietype
Inschrijving (Werkelijk)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
Michigan
-
Grand Blanc, Michigan, Verenigde Staten, 48439
- Ascension Genesys Hospital
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Pregnant women, age 18 - 45, that were admitted for induction of labor without any co-morbid conditions and their respective newborns with
- Induction of labor
- Singleton pregnancies
- Vertex presentation
- Pregnancies at 39 0/7 weeks gestation - 41 6/7 weeks gestation
- All races/ethnicities
Exclusion Criteria:
- Multifetal gestations
- Noncephalic presentation
- Preexisting medical conditions:
- Maternal cardiac disease
- Lung diseases
- Chronic hypertension
- Pregestational or gestational diabetes
- gHTN or Pre-Eclampsia
- medical indication for induction of labor (olighydramnios, IUGR)
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Ondersteunende zorg
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Actieve vergelijker: Primiparous Patient, Unfavorable Bishop Score
Patient to receive D5LR or LR at 125 cc/hr
|
IV fluid
IV fluid
|
|
Actieve vergelijker: Primiparous Patient, Favorable Bishop Score
Patient to receive D5LR or LR at 125 cc/hr
|
IV fluid
IV fluid
|
|
Actieve vergelijker: Multiparous patient, Unfavorable Bishop Score
Patient to receive D5LR or LR at 125 cc/hr
|
IV fluid
IV fluid
|
|
Actieve vergelijker: Multiparous patient, Favorable Bishop Score
Patient to receive D5LR or LR at 125 cc/hr
|
IV fluid
IV fluid
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Time of induction
Tijdsspanne: 492 min +/- 35 min
|
Time from start of labor induction to delivery of infant
|
492 min +/- 35 min
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Time of Active Labor
Tijdsspanne: 4 hours +/- 3 hours
|
time from 6 cm dilation until delivery of infant
|
4 hours +/- 3 hours
|
|
Apgar Scores
Tijdsspanne: 492 min +/- 35 min
|
validated measure of infant health
|
492 min +/- 35 min
|
|
Mode of Delivery
Tijdsspanne: 492 min +/- 35 min
|
Cesarean section vs SVD vs OVD
|
492 min +/- 35 min
|
|
Neonatal ICU admissions
Tijdsspanne: 24 hours after delivery
|
ICU or special care nursery admissions
|
24 hours after delivery
|
|
Need for respiratory support
Tijdsspanne: 24 hours after delivery
|
Neonatal need for respiratory support
|
24 hours after delivery
|
|
Transfer to tertiary care center
Tijdsspanne: 24 hours after delivery
|
neonatal need for transfer to higher level NICU
|
24 hours after delivery
|
Medewerkers en onderzoekers
Sponsor
Publicaties en nuttige links
Algemene publicaties
- Fong A, Serra AE, Caballero D, Garite TJ, Shrivastava VK. A randomized, double-blinded, controlled trial of the effects of fluid rate and/or presence of dextrose in intravenous fluids on the labor course of nulliparas. Am J Obstet Gynecol. 2017 Aug;217(2):208.e1-208.e7. doi: 10.1016/j.ajog.2017.03.010. Epub 2017 Mar 18.
- Sharma C, Kalra J, Bagga R, Kumar P. A randomized controlled trial comparing parenteral normal saline with and without 5% dextrose on the course of labor in nulliparous women. Arch Gynecol Obstet. 2012 Dec;286(6):1425-30. doi: 10.1007/s00404-012-2485-1. Epub 2012 Aug 4.
- ACOG Practice Bulletin No. 107: Induction of labor. Obstet Gynecol. 2009 Aug;114(2 Pt 1):386-397. doi: 10.1097/AOG.0b013e3181b48ef5. No abstract available.
- Committee on Practice Bulletins-Obstetrics. Practice Bulletin No. 183: Postpartum Hemorrhage. Obstet Gynecol. 2017 Oct;130(4):e168-e186. doi: 10.1097/AOG.0000000000002351.
- ACOG Committee Opinion No. 761: Cesarean Delivery on Maternal Request. Obstet Gynecol. 2019 Jan;133(1):e73-e77. doi: 10.1097/AOG.0000000000003006.
- ACOG Committee Opinion No. 766: Approaches to Limit Intervention During Labor and Birth. Obstet Gynecol. 2019 Feb;133(2):e164-e173. doi: 10.1097/AOG.0000000000003074.
- Philipson EH, Kalhan SC, Riha MM, Pimentel R. Effects of maternal glucose infusion on fetal acid-base status in human pregnancy. Am J Obstet Gynecol. 1987 Oct;157(4 Pt 1):866-73. doi: 10.1016/s0002-9378(87)80075-3.
- Pare J, Pasquier JC, Lewin A, Fraser W, Bureau YA. Reduction of total labor length through the addition of parenteral dextrose solution in induction of labor in nulliparous: results of DEXTRONS prospective randomized controlled trial. Am J Obstet Gynecol. 2017 May;216(5):508.e1-508.e7. doi: 10.1016/j.ajog.2017.01.010. Epub 2017 Jan 30.
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Andere studie-ID-nummers
- ME 19 004
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
product vervaardigd in en geëxporteerd uit de V.S.
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op Lactated ringers
-
Second Affiliated Hospital, School of Medicine,...Jinhua People's Hospital; Jinhua Municipal Central Hospital; Yiwu Central Hospital en andere medewerkersWerving
-
Chinese PLA General HospitalNog niet aan het wervenVeiligheid | Effectiviteit | Ringer bicarbonaat | Ouderen Abdominale Chirurgie
-
National Hepatology & Tropical Medicine Research...Voltooid
-
University of CalgaryNog niet aan het wervenPost-ERCP acute pancreatitis
-
Vascular Solutions LLCVoltooidCoronaire stenoseCanada, Verenigde Staten
-
Milton S. Hershey Medical CenterLehigh Valley Hospital; St. Luke's Hospital, Pennsylvania; The Reading Hospital...Voltooid
-
Uppsala UniversityBeëindigdPostoperatieve complicaties | Vloeistof therapie | Vochtteveel | Ziekte van de alvleesklier | Postoperatieve periodeZweden
-
Medical University of ViennaVoltooid
-
K. C. RasmussenVoltooidStoornissen van de stolling
-
Montreal Heart InstituteVoltooidLinkerventrikelfunctie Diastolische dysfunctie | Vloeiende responsiviteitCanada